Navigation Links
Yoghurt To Treat Bowel Infections

A humble tub of yoghurt could contain the cure for certain types of antibiotic-resistant bowel bacteria, according to recent research .

Overuse of antibiotics has led to colonisation of the bowel with antibiotic-resistant bacteria, including vancomycin-resistant enterococci (VRE), which are responsible for persistent and transmissible infections.

Probiotics, found in some commercial yoghurts, may have a beneficial effect on human gut health by helping to restore the normal gut organisms.

Ms Karen Manley, Renal Dietitian at Austin Health, Melbourne, and colleagues conducted a study to determine whether eating yoghurt could help clear VRE from the bowel.

The results of their study are published in the latest issue of the Medical Journal of Australia.

They found that 11 patients who regularly ate yoghurt containing Lactobacillus rhamnosus GG (LGG) bacteria were all free of VRE within 4 weeks.

Of the 12 control patients who ate standard yoghurt without LGG, 10 remained VRE-positive after 4 weeks.

The authors explain that yoghurt containing LGG works because LGG can survive stomach and bile acids to remain in sufficient numbers to reach the bowel.

The study also revealed that LGG bacteria are both resistant and susceptible to a range of antibiotics.

The authors point out that, although there were no adverse effects of LGG detected in their study, safety of the probiotic in patients who are extremely unwell or immunocompromised is uncertain.

They conclude that larger trials and further research are required to investigate the effectiveness of LGG in preventing primary infection.

'"/>




Page: 1

Related medicine news :

1. A Protein In Yoghurt Has The Potential To Fight E. coli
2. Advances in Treatment of Cataracts
3. Recommendations for Treatment of Blood Pressue
4. New FDA Approved Drug To Treat Migraine
5. Treatment for Menieres disease
6. Treatment for pre-menstrual syndrome is ineffective
7. Angiotensin-II-receptor blockers - Treat kidney failure
8. Cipro Has Cheaper Cousins to Treat Anthrax
9. Better Treatment for obesity
10. Gene Treatment for Heart Disease
11. Cyclosporin A Treats Leukemia Complications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... ... August 18, 2017 , ... ... at creating a transparent, verifiable database to help the cannabis industry move towards ... Paragon hopes to deliver a faster technology with lower fees. Paragon will build ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has ... These illustrations show the diversity of the breastfeeding mothers, using bright colors ... of sizes. These illustrations are also available on tote bags, notepads, smartphone cases, ...
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! ... children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A ... a couple from Long Island, New York. , Published by Christian Faith Publishing, Dale ...
(Date:8/18/2017)... York, New York (PRWEB) , ... ... ... International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light ... announced it has entered into a definitive agreement to purchase Unitrans International ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/2/2017)... Calif. , Aug. 2, 2017 ... Continental Who,s Who as a Pinnacle Lifetime Professional ... the Key Account Manager at Turing Pharmaceuticals, AG. ... negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience as ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology: